VPH - Industry Meeting 2010 looks at building a new European industry based on the results of Virtual Physiological Human research

BARCELONA, SPAIN – (HealthTech Wire / News) –Virtual Physiological Human (VPH), a European eHealth project funded by the European Commission, is organising an Industry Meeting in Barcelona, Spain ( 8-9 September) to look into ways of building a new European industry based on the results of research projects involved in developing the Virtual Physiological Human. The two-day meeting will enable the VPH community to showcase its best results to the biomedical industry in order to expand the take-on of VPH technologies in the health industry.   

Call for Abstracts – VPH Research to Business session  
The vision of the Virtual Physiological Human is a grand challenge. A key feature of the VPH initiative is the promise of some low-hanging fruits, applications where the power of multiscale simulation technology can be placed into clinical and industrial practices in the not-so-distant future. Viewed in this light, it is essential for all VPH projects to actively disseminate their research results towards the biomedical industry.   
    
This year the program revolves around three types of sessions: 

• Research to Business (R2B), where research consortia present to industry delegates the best results they achieved;
• Business to Business (B2B), where small and large companies, as well as university spin-offs present products and services that other companies can use to develop other products and services for the final end-user.
•  Regulatory to Business (G2B), where experts of regulatory affair will report on the position of simulation technologies with respect to regulatory affairs.

VPH research projects are invited to participate in this event in three ways:

• Ensuring that industrial partners of each consortia are informed of the event and are motivated to send delegates
• Explore with industrial partners or spin-offs the interest to present their products and services at the B2B session.  Those interested should contact Elena Villalba Mora <villalba_elena “at” cdti.es>.
• Submit an abstract of the presentation on the best research results to be showcased in the R2B session. 

Selection Criteria  
The draft program consists of 12 slots of 30-minutes for each presentation.  In the event that abstracts received exceed the number of available slots, the organisation of the event will make a selection according to the following criteria:

• Fair representation of all projects (if two abstracts come from the same project one might be excluded)   
• Broadest possible coverage of the clinical and industrial domains
• Closeness of results to be presented to the industrial/clinical exploitation 

Instructions for consortia and research groups who wish to present at the VPH-Industry Meeting 2010:

• Submission of abstracts: Abstract must reach the event organisers no later than the 23rd of April 2010. Selected contributions will be invited for presentation during the 8th and 9th of September 2010.   

• Instructions for submission of abstracts: Abstracts should be send to Vanessa Diaz  <v.diaz “at” ucl.ac.uk>.  Abstracts will be between 350 and 500 words long, without including the title and the authors.  The format is free; illustrations can be included. 

• Abstract contents: Abstracts should cover these topics:   subject of research, clinical and / or industrial translation, clinical uptake, development of tools if any. 

• Evaluation: The event organisers will evaluate all abstracts.  Notification of acceptance will be provided the last week of April.

###